Par Drugs and Chemicals Limited
NSE:PAR.NS
302.6 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 366.539 | 222.43 | 162.064 | 211.638 | 73.792 | 0.306 | 0.637 | 0.184 | 9.295 |
Short Term Investments
| 31.306 | 30.016 | 10.016 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 366.539 | 222.43 | 162.064 | 211.638 | 73.792 | 0.306 | 0.637 | 0.184 | 9.295 |
Net Receivables
| 138.09 | 218.151 | 217.374 | 170.25 | 139.225 | 98.559 | 87.573 | 94.717 | 73.767 |
Inventory
| 41.77 | 53.79 | 47.127 | 29.967 | 29.168 | 42.942 | 40.675 | 39.889 | 59.762 |
Other Current Assets
| 49.837 | -0.001 | 9.074 | 0 | -0 | 0.035 | 98.955 | 1.033 | 3.325 |
Total Current Assets
| 596.236 | 494.37 | 435.639 | 411.855 | 242.185 | 141.842 | 140.267 | 135.823 | 146.149 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 413.349 | 386.945 | 343.514 | 343.709 | 351.352 | 363.41 | 390.349 | 415.32 | 426.088 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| -0.4 | -0.7 | -1.2 | -1.407 | -1.259 | -1.64 | -3.477 | -8.484 | 0 |
Long Term Investments
| 0.119 | 0.1 | 0.1 | 0.1 | 0.565 | 0.565 | 0.565 | 0.565 | 0.565 |
Tax Assets
| 0.4 | 0.7 | 1.2 | 1.407 | 1.259 | 1.075 | 2.912 | 7.919 | 0 |
Other Non-Current Assets
| 6.407 | 7.264 | 7.649 | 8.176 | 7.05 | 8.304 | 8.77 | 9.272 | 7.506 |
Total Non-Current Assets
| 419.875 | 394.309 | 351.263 | 351.986 | 358.967 | 371.714 | 399.119 | 424.592 | 434.159 |
Total Assets
| 1,016.111 | 888.679 | 786.902 | 763.841 | 601.152 | 513.555 | 539.389 | 560.414 | 580.308 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 53.562 | 80.915 | 106.618 | 67.178 | 62.045 | 49.318 | 52.613 | 77.831 | 64.354 |
Short Term Debt
| -0.051 | -0.623 | -0.09 | 39.294 | 13.925 | 55.496 | 100.556 | 105.076 | 142.613 |
Tax Payables
| 49.756 | 0 | 0 | 33.61 | 10 | 6.78 | 5.205 | 6.49 | 0 |
Deferred Revenue
| 0.051 | 0.623 | 0.09 | 46.528 | 29.982 | 16.468 | 10.04 | 10.296 | 0 |
Other Current Liabilities
| 70.829 | 58.979 | 41.956 | 6.792 | 2.489 | 3.274 | 3.491 | 2.726 | 12.914 |
Total Current Liabilities
| 124.391 | 139.894 | 148.574 | 159.792 | 108.442 | 124.556 | 166.7 | 195.929 | 219.881 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 0 | 0 | 0 | 43.918 | 46.191 | 60.313 | 130.695 | 143.008 | 164.884 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 47.853 | 50.053 | 3.269 | 2.633 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 35.4 | 35 | 35.5 | 34.051 | 36.512 | 34.243 | 32.372 | 27 | 0 |
Other Non-Current Liabilities
| -0 | 1.402 | 4.056 | -43.918 | -46.191 | 0.001 | 0.003 | 2.444 | 21.986 |
Total Non-Current Liabilities
| 35.4 | 36.402 | 39.556 | 81.903 | 86.565 | 97.826 | 165.703 | 172.452 | 186.87 |
Total Liabilities
| 159.791 | 176.296 | 188.13 | 241.695 | 195.007 | 222.382 | 332.403 | 368.381 | 406.751 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 57.5 | 57.5 | 57.5 |
Common Stock
| 123.046 | 123.046 | 123.046 | 61.523 | 61.523 | 44.803 | 27 | 27 | 27 |
Retained Earnings
| 625.512 | 481.575 | 367.964 | 291.337 | 175.337 | 145.637 | 121.45 | 106.497 | 88.371 |
Accumulated Other Comprehensive Income/Loss
| 733.274 | 1.036 | 1.036 | 1.036 | 1.036 | 1.036 | -57.5 | -57.5 | 0.686 |
Other Total Stockholders Equity
| -625.512 | 106.726 | 106.726 | 168.249 | 168.249 | 99.697 | 58.536 | 58.536 | 0 |
Total Shareholders Equity
| 856.32 | 712.383 | 598.772 | 522.145 | 406.145 | 291.173 | 206.986 | 192.033 | 173.557 |
Total Equity
| 856.32 | 712.383 | 598.772 | 522.145 | 406.145 | 291.173 | 206.986 | 192.033 | 173.557 |
Total Liabilities & Shareholders Equity
| 1,016.111 | 888.679 | 786.902 | 763.841 | 601.152 | 513.555 | 539.389 | 560.414 | 580.308 |